Information Provided By:
News For ALKS From the Last 2 Days
ALKS
Apr 15, 2024 | 07:36 EDT
UBS lowered the firm's price target on Alkermes to $23 from $25 and keeps a Sell rating on the shares. UBS believes Alkermes stock will likely continue to underperform, as the FY24 guidance seems unachievable and there are no pipeline catalysts remaining for the year, the analyst tells investors in a research note.